![]() |
Phase II case-control trial initiated for four types of terminal cancers
The Alexandrov National Cancer Centre begins phase II case-control clinical trial of its immuno-oncology agent, Elenagen.
More... |
| All times are GMT -7. The time now is 11:07 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021